|
|
|
|
REFERENCES
Fisher B, Costantino JP, Redmond CK, et al.: Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast
and Bowel Project (NSABP) b-14. J Natl Cancer Inst 86:527-537, 1994. Hiatt RA, Tolan K and Quesenberry CP Jr: Renal cell carcinoma and thiazide use: a historical, case-control study. Cancer Causes Control 5:319-325, 1994. Hoover R and Fraumeni JF Jr: Drug-induced cancer.
Cancer, 47:1071-1080, 1981. Hoover R: Effects of drugs: immunosuppression. (Hiatt, Watson, Winsten, eds.). In Origins of Human Cancer. Cold Spring Harbor Lab. Press 369-379, 1977. Hoover RN: Cancer induced by cancer treatment. (Fortner, Rhoads, eds.). In Accomplishments in Cancer Research, 1992. Philadelphia: J.B. Lippincott, 1994, 229-239. Kinlen LJ: Immunosuppressive therapy and acquired immunological disorders. Cancer Res [suppl] 52:5474s-5476s, 1992. Nayfield S, Karp JE, Ford LG, et al.: Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83:1450-1459, 1991. Thun MJ, Namboodiri MM, Heath CW Jr: Aspirin use
and reduced risk of fatal colon cancer. N Engl J Med 325(23):1593-1596, 1991. |
